Cipla Limited(NSE: CIPLA) posted its second-quarter 2022 results. The company posted consolidated revenue of ₹5,580 crores with a growth of 9% year
Infographic: How Cipla performed in Q2 2022
Categories
pharmaceuticals
IOL Chemicals and Pharmaceuticals Ltd (IOLCP) Q2 FY22 Earnings Concall Transcript
IOL Chemicals and Pharmaceuticals LTd (NSE:IOLCP) Q2 FY22 Earnings Concall dated Nov. 16, 2021 Corporate Participants: Monish Shah -- Vice President, Research Sanjay
Earnings: Aurobindo Pharma results in Q2 2022
Aurobindo Pharma (NSE: AUROPHARMA) reported its second-quarter 2022 earnings results today. The company had a consolidated net profit of ₹696.71 crores with
Key highlights from Sun Pharma Q2 2022 earnings results
Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its second-quarter 2022 earnings results today. The company reported consolidated revenue of ₹98.4 billion with a
Cipla Ltd (CIPLA) Q2 FY22 Earnings Concall Transcript
Cipla Limited (NSE: CIPLA) Q2 FY22 Earnings Concall dated Oct. 26, 2021 Corporate Participants: Naveen Bansal -- Director, Finance Kedar Upadhye -- Global
Key highlights from Dr Reddy’s Q2 2022 earnings results
Dr Reddy’s Laboratories (NSE: DRREDDY) reported its second-quarter financial results for the period ended September 30, 2021. The company had total revenue
How Cipla performed in Q2 2022
The pharma giant Cipla (NSE: CIPL) reported its second-quarter 20223 earnings results on Tuesday after market hours. The total revenue increased by
IPO Alert: What to expect when Emcure Pharma hits public markets
India's domestic pharmaceutical market is estimated at $42 billion in 2021. It is likely to reach $65 billion by 2024 and further
Ami Organics files IPO worth ₹300 crore
The pharmaceutical market in India was valued at $59 billion in 2020 and supplies over 50% globally for various vaccines. The IPOs
Alembic Pharmaceuticals Ltd. (APLLTD) Q4 FY21 Earnings Concall
Alembic Pharmaceuticals Ltd. (NSE:APLLTD) Q4 FY21 Earnings Concall dated May 04, 2021
Cipla Ltd (CIPLA) Q3 FY21 Earnings Concall Transcript
Cipla Limited (NSE:CIPLA) Q3 FY21 earnings concall dated Jan. 29, 2021. Corporate Participants: Kumar Gaurav -- Vice President, Kotak Institutional Equities Naveen
Alembic Pharmaceuticals Limited (APLLTD) Q3 FY21 Earnings Concall Transcript
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q3 FY21 earnings concall dated Jan. 19, 2021. Corporate Participants: R. K. Baheti -- Director - Finance &